SCHEMBL6170274

SCHEMBL6170274

CNS(=O)(=O)Nc1cc(C(C)C2(C(C)c3ccnc(NS(=O)(=O)NC)c3)NC(=O)N(c3ccc(OC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 5/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
AR P10275 1/20 0.33
IGF1R P08069 1/20 0.33
MAPT P10636 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PDE2A O00408 3/20 0.32
MAPK1 P28482 2/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
LIPE Q05469 1/20 0.32
PLK1 P53350 1/20 0.32
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172534 0.91 IGF1R (0.40) GPR139POLBL3MBTL1TSHRKMT2A
SCHEMBL6174207 0.90 TSHR (0.35) GPR139POLBL3MBTL1TSHRKMT2A
SCHEMBL6171179 0.89 POLB (0.37) GPR139POLBL3MBTL1TSHRKMT2A
SCHEMBL6172683 0.88 MAPK1 (0.38) GPR139TSHRKMT2AIGF1RMAPK1
SCHEMBL6172626 0.87 IGF1R (0.40) GPR139POLBL3MBTL1TSHRKMT2A
SCHEMBL6174561 0.85 IGF1R (0.40) GPR139POLBL3MBTL1TSHRKMT2A
SCHEMBL6176554 0.84 BRAF (0.42) KMT2AIGF1RMAPTCYP3A4GAA
SCHEMBL6173261 0.83 IGF1R (0.41) TSHRKMT2AIGF1RABL1BCR
SCHEMBL6174008 0.82 POLB (0.41) GPR139POLBL3MBTL1KMT2AAR
SCHEMBL17558396 0.82 POLB (0.39) GPR139POLBL3MBTL1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed